Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02180841 · ClinicalTrials.gov registry record · NA
Effect of Soy on HDL-C Function, Central Blood Pressure, and Arterial Stiffness
A NA study, sponsored by Penn State University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02180841 is a NA study that has completed, run by Penn State University. The registered enrollment target is 20 participants.
The verdict
NCT02180841, a NA study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of the proposed pilot study is to evaluate the effects of a soy protein isolate with naturally occurring isoflavones on the properties of HDL-C (total HDL-C, HDL particle size and HDL function), central blood pressure, and indices of arterial stiffness.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Soy Protein Powder (25g/d)
- DIETARY_SUPPLEMENT Soy Protein Powder (50g/d)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02180841
The ClinicalTrials.gov registry entry for NCT02180841 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02180841 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02180841 about?
NCT02180841 is a clinical study titled "Effect of Soy on HDL-C Function, Central Blood Pressure, and Arterial Stiffness". The purpose of the proposed pilot study is to evaluate the effects of a soy protein isolate with naturally occurring isoflavones on the properties of HDL-C (total HDL-C, HDL particle size and HDL function), central blood pressure, and indices of arterial stiffness.
What is the current status of trial NCT02180841?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2014-03. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02180841?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Soy Protein Powder (25g/d) (DIETARY_SUPPLEMENT), Soy Protein Powder (50g/d) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02180841?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.